Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
SensArs Neuroprosthetics Sarl is a pioneering startup specializing in neuroprosthetic systems that aim to restore sensory feedback for individuals with limb loss. By implanting electrodes in the peripheral nerves and utilizing a unique closed-loop system, SensArs' technology revives communication between nerve-damaged areas and the brain, effectively eliminating chronic pain. The startup has successfully conducted human clinical trials, receiving FDA Breakthrough Device Designation for its innovative approach. SensArs has garnered recognition for its breakthrough technology, including a EUR3 million grant from the European Union's Horizon Research and Innovation program and being named one of the 'Top 20 Most Innovative Companies to Watch' by Business Worldwide Magazine in 2022.